de Jong PE - Search Results

1

Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.

Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, De Zeeuw D, de Jong PE; PREVEND Study Group. Prevention of Renal and Vascular End-stage Disease. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Clin Chem Lab Med. 2000 Nov;38(11):1107-10. doi: 10.1515/CCLM.2000.165. Clin Chem Lab Med. 2000. PMID: 11156337

2

Involvement of atrial natriuretic peptide in long-term regulation of sodium-homeostasis in man.

Janssen WM, de Jong PE, van der Hem GK, de Zeeuw D. Janssen WM, et al. Among authors: de jong pe, de zeeuw d. Clin Nephrol. 1988 Sep;30(3):172. Clin Nephrol. 1988. PMID: 2972429 No abstract available.

3

Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension.

Navis G, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D. Navis G, et al. Among authors: de jong pe, de zeeuw d. J Clin Hypertens. 1985 Sep;1(3):228-38. J Clin Hypertens. 1985. PMID: 3012004

4

Reduction of proteinuria by angiotensin converting enzyme inhibition.

Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1987 Jul;32(1):78-83. doi: 10.1038/ki.1987.174. Kidney Int. 1987. PMID: 3041097 Free article.

5

Is the antiproteinuric effect of dipyridamole hemodynamically mediated?

de Jong PE, van der Meer J, van der Hem GK, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. Nephron. 1988;50(4):292-4. doi: 10.1159/000185190. Nephron. 1988. PMID: 3070413

6

Effect of mild charge modification of albumin on renal excretion in the rat.

de Zeeuw D, Tomasini R, Haas M, de Jong PE, Weening JJ, van der Hem GK. de Zeeuw D, et al. Among authors: de jong pe. Contrib Nephrol. 1988;68:121-7. doi: 10.1159/000416502. Contrib Nephrol. 1988. PMID: 3233990 No abstract available.

7

Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.

Vriesendorp R, de Zeeuw D, de Jong PE, Donker AJ, Pratt JJ, van der Hem GK. Vriesendorp R, et al. Among authors: de jong pe, de zeeuw d. Clin Nephrol. 1986 Feb;25(2):105-10. Clin Nephrol. 1986. PMID: 3516475

8

The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.

de Zeeuw D, Navis GJ, Donker AJ, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. J Hypertens Suppl. 1983 Oct;1(1):93-7. J Hypertens Suppl. 1983. PMID: 6100614 Clinical Trial.

9

Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity?

de Jong PE, Saleh AW, de Zeeuw D, Donker AJ, van der Hem GK, Pratt JJ, Sewrajsingh GS, Statius van Eps LW. de Jong PE, et al. Among authors: de zeeuw d. Clin Nephrol. 1984 Oct;22(4):212-3. Clin Nephrol. 1984. PMID: 6595096 No abstract available.

10

The influence of indomethacin on renal concentrating and diluting capacity in sickle cell nephropathy.

De Jong PE, De Jong-van den Berg LT, De Zeeuw D, Donker AJ, Schouten H, Statius van Eps LW. De Jong PE, et al. Among authors: de jong van den berg lt, de zeeuw d. Clin Sci (Lond). 1982 Jul;63(1):53-8. doi: 10.1042/cs0630053. Clin Sci (Lond). 1982. PMID: 7083765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters